This is a split-mouth randomized clinical investigation conducted to evaluate clinical performances of a self-adhesive hybrid resin composite (investigational medical device Surefil) compared to a traditional composite resin, when used for direct restorations of non-carious lesions (NCCLs). The study consists of a 3-year long follow-up period.
The aim of this study is to demonstrate non-inferiority in terms of clinical performance and patient discomfort after direct restorative treatment of class V NCCL with Surefil one restorative material (Dentsply Sirona) in combination with a traditional paste composite "Venus Pearl" employed in combination with iBond universal adhesive (Kulzer Dental) during an observational period of 3 years.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
16
Restorative material (Dentsply Sirona). Used for direct restoration of class V NCCL.
Restorative material. Traditional paste composite employed in combination with iBond universal adhesive.
Clinica Odontoiatrica (DIBINEM)
Bologna, Italy
Assessment of Restorative Quality
The restorations will be evaluated using the World Dental Federation (FDI) criteria.
Time frame: At 36 months follow-up.
Assessment of Restorative Quality
The restorations will be evaluated using the United States Public Health Service (USPHS) criteria.
Time frame: At 36 months follow-up
Assessment of Restorative Quality
The restorations will be evaluated using the FDI criteria.
Time frame: At 6, 12 and 24 months follow-up
Assessment of Restorative Quality
The restorations will be evaluated using the USPHS criteria.
Time frame: At 6, 12 and 24 months follow-up
Assessment of Aesthetics
The aesthetic integration of the restoration will be evaluated by two experienced and blinded operators following the aesthetic criteria of the FDI.
Time frame: At 6, 12, 24 and 36 months follow-up
Level of Pain
Sensitivity index: thermal yes/no, if yes then Visual Analogue Scale (VAS) index for level of pain. Air yes/no, if yes then VAS index for level of pain.
Time frame: At 6, 12, 24 and 36 months follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.